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Abstract: The superiority of distinct anesthesia methods for geriatric hip fracture surgery remains
unclear. We evaluated high mobility group box-1 (HMGB1) and interleukin-6 (IL-6) with three
different anesthesia methods in elderly patients undergoing hip fracture surgery. Routine blood
test findings, postoperative morbidity, and mortality were assessed as secondary outcome. In total,
176 patients were randomized into desflurane (n = 60), propofol (n = 58), or spinal groups (n = 58)
that received desflurane-based balanced anesthesia, propofol-based total intravenous anesthesia
(TIVA), or spinal anesthesia, respectively. The spinal group required less intraoperative vasopressors
(p < 0.001) and fluids (p = 0.006). No significant differences in HMGB1 (pgroup×time = 0.863) or IL-6
(pgroup×time = 0.575) levels were noted at baseline, postoperative day (POD) 1, or POD2. Hemoglobin,
albumin, creatinine, total lymphocyte count, potassium, troponin T, and C-reactive protein were
comparable among groups at all time-points. No significant differences in postoperative hospital
stay, intensive care unit (ICU) stay, and ventilator use among groups were observed. Postoperative
pulmonary, cardiac, and neurologic complications; and in-hospital, 30-day, and 90-day mortality
were not significantly different among groups (p = 0.974). In conclusion, HMGB1 and IL-6, and all
secondary outcomes, were not significantly different between desflurane anesthesia, propofol TIVA,
and spinal anesthesia.
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1. Introduction
Hip fracture is a surgical disease, with more than 95% of patients undergoing operative treatment [1].
The majority of hip fractures are complicated by the fact that the patient population is geriatric with
various underlying medical conditions. In Europe and the USA, the 1-month mortality rate after hip
fracture is reported to be between 4% and 12%, and as high as 35% after 1 year [2]. To improve patient
outcomes, substantial research efforts are being enacted.
Two important facets of the surgical management of elderly hip fracture patients are the utility of
laboratory tests for predicting outcomes and optimal anesthetic method. Several laboratory tests have
been suggested to be predictive of mortality after hip fracture surgery, which include routine blood tests
such as hemoglobin (Hb), total lymphocyte count (TLC), albumin, and creatinine [3]; and cytokines
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such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-10 (IL-10) [4]. Notably,
the superiority of different methods of anesthesia in terms of clinical outcomes after hip fracture
surgery is the focus of many researchers in the field. In this context, we focused on high mobility group
box-1 (HMGB1), which acts as a damage-associated molecular pattern molecule that mediates the
noninfectious inflammatory response, and its significance in traumatic hip fracture surgery. The clinical
significance of HMGB1, a relatively novel inflammatory cytokine, has been reported in various diseases
including cancer, inflammatory diseases, autoimmune diseases, and trauma [5]. While studies have
reported greater benefit with regional anesthesia over general anesthesia, recent data suggest that
clinical outcomes between these anesthetic methods are not significantly different [6].
The primary purpose of this study was to evaluate the potential differences in HMGB1 and IL-6
between elderly patients undergoing surgical treatment for hip fractures with either general or spinal
anesthesia. To further differentiate between anesthesia methods, general anesthesia was divided
into desflurane-based balanced anesthesia or total intravenous anesthesia (TIVA) with propofol.
As secondary outcomes, we investigated whether different anesthesia methods would lead to a
difference in morbidity and mortality after hip fracture surgery, and additionally analyzed routine
laboratory test results that had been previously reported to be associated with outcome in hip
fracture patients.
2. Materials and Methods
2.1. Study Population and Anesthesia Procedure
The study protocol was reviewed and approved by the Institutional Review Board and Hospital
Research Ethics Committee of Severance Hospital, Yonsei University Health System (#4-2015-0088) and
registered at http://clinicaltrials.gov (NCT02458547). Written informed consent was obtained from all
patients. Patients over the age of 65 years that received daytime hip fracture surgery between May 2015
and January 2019 were screened and enrolled in this study. Patients with absolute contraindications to
spinal anesthesia, known allergies to propofol, and altered mental status due to intracranial lesions
were excluded. Patients previously diagnosed with dementia or those showing signs of delirium were
enrolled after consent was obtained from a legal representative. Attempts to obtain consent from such
patients were continuously made throughout the study period when the patient was deemed lucid per
the guidelines of our Hospital Research Ethics Committee.
Patients were randomly assigned to either the desflurane, propofol, or spinal groups on the day
of surgery according to a random table generated by a computer program. Patient allocation was
performed by an investigator that was not involved in postoperative assessment. The investigator in
charge of postoperative follow-up remained blinded to the method of anesthesia.
Upon arrival at the operating room, electrocardiography, non-invasive blood pressure, and pulse
oximetry monitors were applied. Arterial cannulation for invasive blood pressure monitoring was
performed when deemed necessary by the attending anesthesiologist. In the desflurane group, patients
received pentothal sodium, cisatracurium, and remifentanil for induction. Anesthesia was maintained
with desflurane in oxygen-air mixture (40:60) and remifentanil infusion. Patients in the propofol group
received propofol, remifentanil, and cisatracurium for anesthesia induction and were maintained with
target-controlled infusion (TCI) of propofol and remifentanil based on the Marsh [7] and Minto [8]
model for the two drugs, respectively. In patients that underwent general anesthesia, intraoperative
bispectral index (BIS) monitors were used. BIS levels were maintained between 40 and 60. Patients in
the spinal group received spinal anesthesia with hyperbaric bupivacaine and were administered 3 L
of O2 via nasal prong. The dose of hyperbaric bupivacaine used was 9 mg in patients shorter than
160 cm, and 11 mg in those 160 cm or taller. Patients that requested or required intraoperative sedation
were administered midazolam starting at doses of 0.02 mg/kg.
A significant decrease in blood pressure (greater than 20% decrease in mean arterial pressure from
baseline) was considered hypotension and was initially treated with a bolus of ephedrine (4 mg) up
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to two times. If hypotension persisted, additional ephedrine, phenylephrine, or norepinephrine was
administered at the discretion of the attending anesthesiologist based on the patient’s vital signs and
underlying medical conditions.
2.2. Outcome Assessment
HMGB1 and IL-6 were measured three times: on the morning of surgery as baseline, postoperative
day (POD) 1 and POD2. Peripheral blood samples were centrifuged immediately after collection.
Serum was frozen and stored at −80 ◦C until analysis. Serum HMGB1 was quantified by enzyme-linked
immunosorbent assay (ELISA) using the HMGB1 ELISA kit (IBL International, Hamburg, Germany)
according to the manufacturer’s instructions. Plasma IL-6 was analyzed using the Human IL-6
Quantikine ELISA Kit (R&D Systems, Inc., Minneapolis, MN).
Hb, TLC, creatinine, albumin, potassium, troponin T, and C-reactive protein (CRP) levels were
compared among groups at three-time points: on the morning of surgery as baseline, POD1, and POD2.
N-terminal pro-brain natriuretic peptide (NT-proBNP) level was evaluated once at baseline.
Intraoperative fluid input, blood loss, and amount of transfusion were recorded alongside the
use of intraoperative vasopressors. Postoperative complications were categorized as pulmonary
(pneumonia, respiratory failure), cardiac (myocardial infarct, heart failure, new-onset arrhythmia),
and neurologic (aggravation or new onset of delirium). Postoperative hospital stay, duration of intensive
care unit (ICU) admission, and ventilator use were also recorded and compared among groups. Mortality
rates were assessed during the postoperative period at the hospital and up to 90 days after surgery.
2.3. Statistical Analysis
Sample size calculation was performed based on a previous study that quantified the concentration
of HMGB1 in patients sustaining femur fractures after blunt trauma [9]. HMGB1 level on day 3 after
admission was 53 ± 17 ng/mL in patients whose femoral fractures were stabilized by surgery within 24 h of
injury. Under the assumption that preoperative baseline HMGB1 levels would be comparable between
groups, we hypothesized that a 10 ng/mL difference would be clinically significant on POD2. To obtain 90%
power with an α of 0.05, a sample size of 62 per group was required, allowing for a dropout rate of 10%.
Continuous variables that were normally distributed were analyzed with ANOVA, and multiple
comparisons were performed with an independent t-test. Variables that were not normally distributed
were analyzed with the Kruskal-Wallis test, and multiple comparisons were performed using the
Dunn procedure. Repeated measures variables were analyzed using a linear mixed model with patient
indicator as a random effect and group, time, and group-by-time as fixed effects. The group-by-time
interaction assessed whether the change in variables over time differed between groups. Values
are presented as mean (SD), median (interquartile range, IQR), mean (SEM), or number of patients
(proportion) as appropriate. A p-value < 0.05 was considered statistically significant. All analyses
were conducted using R package, version 3.4.4 (The R Foundation for Statistical Computing, Vienna,
Austria), SAS version 9.4 (Cary, NC, USA), and SPSS Statistics version 25 (Armonk, NY, USA).
3. Results
3.1. Study Population, Demographic Data, and Perioperative Characteristics
The CONSORT (Consolidated Standards of Reporting Trials) flow diagram is shown in Figure 1.
A total of 198 patients admitted for surgery for femur fractures were assessed for eligibility. Twelve
patients were excluded for not meeting the inclusion criteria. The 186 remaining patients were
randomly allocated to the desflurane, propofol, and spinal groups. Two, four, and one patient in the
desflurane, propofol, and spinal groups, respectively, withdrew from the study. An additional three
patients were excluded from the spinal group when the spinal block failed, and the patient received
a different type of anesthesia. None of the patients were lost to follow-up after surgery. The final
analysis comprised 60, 58, and 58 patients in the desflurane, propofol, and spinal groups, respectively.
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Figure 1. CONSORT (Consolidate Standards of Reporting Trials) flowchart of patient sample selection.
Patient characteristics are shown in Table 1. No differences were observed in patient age, sex,
body mass index, or underlying comorbidities between the three groups. Baseline NT-proBNP, type of
fracture, and time from injury to surge y were also similar betw en groups.
Table 1. Patient characteristics.
Desflurane (n = 60) Propofol (n = 58) Spinal (n = 58) p-Value
Age (years) 79.4 ± 7.7 80.5 ± 6.7 81.6 ± 6.7 0.234
Male 13 (21.7%) 16 (27.6%) 17 (29.3%) 0.611
Body mass index (kg/m2) 22.5 (20.0, 24.8) 22.3 (19.6, 24.8) 22.8 (20.4, 25.1) 0.787
Comorbidities
Dementia 12 (20.0%) 7 (12.1%) 10 (17.2%) 0.500
Previous CVA 17 (28.3%) 14 (24.1%) 11 (19.0%) 0.490
CAD 15 (25. %) 14 (24.1 ) 12 (20.7 ) 0.843
COPD 2 (3.3%) 1 (1.7%) 5 (8.6%) 0.175
DM 24 (40.0%) 25 (43.1%) 18 (31.0%) 0.380
Hypertension 44 (73.3%) 43 (74.1%) 45 (77.6%) 0.853
Renal dysfunction 8 (13.3%) 12 (20.7%) 13 (22.4%) 0.405
Baseline NT-proBNP 267 (147, 747) 404 (140, 1022) 250 (168, 631) 0.642
Type of fracture 0.170
Femoral neck 26 (43.3%) 26 (44.8%) 36 (62.1 )
Intertrochanteric 27 (45.0%) 29 (50.0%) 21 (36.2%)
Subtrochanteric 3 (5.0%) 1 (1.7%) 0
Other 4 (6.7%) 2 (3.4%) 1 (1.7%)
Time from injury to surgery (h) 78.5 (46.8, 150.5) 58.0 (39.3, 138.8) 76.0 (52.0, 140.8) 0.278
Time from admission to surgery (h) 46.5 (24.0, 71.0 42.0 (22.8, 70.0) 47.5 (24.0, 72.0) 0.951
Values are mean ±SD or median (interquartile range, IQR); CVA, cerebrovascular accident; CAD, coronary artery
disease; COPD, ch onic obstructive pulmonary disease; DM, diabetes mellitus; NT-proBNP, N-terminal pro-brain
natriuretic peptide.
Operative characteristics are shown in Table 2. All patients underwent either bipolar
hemiarthroplasty or internal fixation of the femur. No difference in type of surgery among the
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three groups was noted. Anesthesia time was comparable between groups. Patients in the spinal
group required significantly less intraoperative vasopressors (p < 0.001) and were administered less
intraoperative fluids (p = 0.006) than that of the other two groups. The remaining variables were
otherwise unremarkable.
Table 2. Operative characteristics.
Desflurane (n = 60) Propofol (n = 58) Spinal (n = 58) Overall p-Value
Type of surgery 0.235
Bipolar hemiarthroplasty 29 (48.3%) 25 (43.1%) 34 (58.6%)
Internal fixation 31 (51.7%) 33 (56.9%) 24 (41.4%)
Anesthesia time (min) 110 (100, 145) 115 (100, 144) 108 (96, 134) 0.405
Fluid balance
Crystalloid (mL) 600 (438, 850) 600 (450, 850) 500 (400, 688) *,† 0.006
Colloid (mL) 0 (0, 0) 0 (0, 0) 0 (0, 100) 0.227
Urine output (mL) 100 (50, 200) 100 (51, 150) 100 (30, 150) 0.412
Blood loss (mL) 100 (50, 200) 100 (50, 200) 85 (50, 138) 0.344
Transfusion
Amount of pRBC (U) 0 (0, 0) 0 (0, 1) 0 (0, 0) 0.047
Vasopressor use 37 (61.7%) 34 (58.6%) 16 (27.6%) *,† 0.000
Values are number (percent) or median (IQR); pRBC, packed red blood cells. * p < 0.05 compared with the desflurane
group. † p < 0.05 compared with the Propofol group. Vasopressor use: multiple boluses of ephedrine (>8 mg) or
phenylephrine/norepinephrine administration.
3.2. Proinflammatory Cytokines and Routine Laboratory Tests
Serum cytokine levels at three time-points are shown in Figure 2. HMGB1 levels were comparable
between the three groups at all-time points. Changes in HMGB1 levels over time were similar in all
groups (pgroup×time = 0.863). The only difference observed was a decrease in HMGB1 level on POD2 in
the desflurane and spinal groups, whereas it continued to increase in the Propofol group. IL-6 levels
were similar among groups at all-time points. No changes over time were observed (pgroup×time = 0.575).
IL-6 levels peaked on POD1 and showed a decreasing trend on POD2.
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Figure 2. Proinflammatory cytokines in elderly patients undergoing hip fracture surgery. High mobility
group box-1 (HMGB1) (A) and interleukin-6 (IL-6) (B) levels at baseline, postoperative day (POD)1,
and POD2 of patients in the three groups. The whiskers represent the SEM.
Results of routine laboratory tests including Hb, albumin, creatinine, TLC, potassium, troponin T,
and CRP are shown in Figure 3. No significant differences were observed in any of these variables
among groups over time. A clear trend of decreasing Hb was observed in all three groups without
significant differences between groups (pgroup×time = 0.434). Variables that continued to increase from
baseline to POD2 were troponin T and CRP.
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3.3. Postoperative Morbidity and Mortality
The duration of hospital stay was similar between the three groups, the median duration being
approximately 1 week. The duration of ICU stay, ventilator use and postoperative stay were also
all comparable between groups. The incidence of pulmonary, cardiac complications, and delirium;
and in-hospital, 30-day, and 90-day, mortality were not significantly different among groups (Table 3).
Figure 4 depicts 90-day survival (p = 0.974).
Table 3. Postoperative morbidity and mortality.
Desflurane (n = 60) Propofol (n = 58) Spinal (n = 58) p Value
Hospital days 6.5 (4.8, 9.0) 7.0 (5.0, 9.0) 7.0 (5.0, 11.0) 0.416
ICU days 0.0 (0.0, 0.0) 0.0 (0.0, 2.0) 0.0 (0.0, 0.0) 0.049
Ventilator days 0.0 (0.0, 0.0) 0.0 (0.0, 0.0) 0.0 (0.0, 0.0) 0.792
Postoperative days 3.0 (3.0, 5.0) 3.0 (3.0, 6.0) 4.0 (3.0, 6.0) 0.573
In-hospital complications
Pulmonary complications 4 (6.7%) 5 (8.6%) 4 (6.9%) 0.907
Cardiac complications 3 (5.0%) 2 (3.4%) 2 (3.4%) 0.883
Delirium 9 (15.0%) 8 (13.8%) 8 (13.8%) 0.977
Postoperative mortality
In-hospital mortality 1 (1.7%) 0 2 (3.4%) 0.357
30-day mortality 2 (3.3%) 1 (1.7%) 1 (1.7%) 0.794
90-day mortality 3 (5.0%) 2 (3.4%) 3 (5.2%) 0.886
Values are number (percent) or median (IQR). ICU, intensive care unit. Pulmonary complications: Pneumonia,
respiratory failure. Cardiac complications: Myocardial infarct, heart failure, new-onset arrhythmia after surgery.
Delirium: Aggravation or new-onset delirium after surgery.
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4. Discussion
Hip fracture surgery is the most common reason for urgent surgery in the geriatric population,
and has been termed the “quintessential geriatric illness” [10]. In this vulnerable patient population,
it is crucial to optimize each component of medical care. One such component is the method of
anesthesia. The most recent systematic reviews to date conclude that clinical outcomes are not
J. Clin. Med. 2020, 9, 1605 8 of 12
significantly different between modes of anesthesia, and the present study supports these previous
findings [6,11,12]. We further categorized general anesthesia into volatile anesthetic-based balanced
anesthesia (desflurane in this case), or TIVA with propofol, but did not observe any differences in
HMGB1 or IL-6 between anesthesia methods. Other routine laboratory results that were assessed as
secondary outcome were also not different between groups, as well as postoperative clinical outcomes.
For several decades, it was unclear whether general or regional anesthesia was favorable for hip
fracture surgery outcomes, and this issue remains under debate. Currently, two large scale, multicenter
randomized clinical trials (RCTs) comparing outcomes after spinal vs. general anesthesia for hip
fracture surgery are underway [2,13], which will provide valuable data and insight regarding this
issue. A limited number of RCTs to date have compared outcomes after different anesthesia techniques
in hip fracture patients. Although it should be noted that anesthetics used in several studies differ
substantially from those commonly used at present, two earlier studies of more than 500 patients
both concluded that there were no differences in morbidity or mortality between spinal and general
anesthesia for hip fracture surgery [14,15]. Two more recent RCTs [16,17] also reported the same
conclusion, although both enrolled patients 50 years or older. Similar results were reported in major
retrospective [18] and observational [19] studies, where 18,158 and 65,535 patients were analyzed,
respectively. The novelty of our study is that it is of the first RCTs to compare not only general vs.
spinal anesthesia, but also inhalational anesthesia with TIVA in elderly hip fracture patients.
The primary goal of the present study was to assess differences in the cytokines, HMGB1 and
IL-6, among desflurane-based balanced anesthesia, propofol-based TIVA, and spinal anesthesia.
The two cytokines were selected based on the extensive literature on IL-6 and more recent interest in
HMGB1. The role of IL-6 in chronic inflammation and autoimmune diseases is well established. IL-6
has been proposed as a marker for predicting outcomes after hip fracture in elderly patients [4,20].
As a mediator of sterile inflammation and infection, HMGB1 has an important role in injury-elicited
inflammatory diseases including trauma [9,21,22], but evidence in elderly hip fracture patients is
lacking. The significance of HMGB1 in clinical practice has been reported in countless disease states,
which include various forms of trauma [5]. HMGB1 has been suggested to have prognostic value in
severe trauma patients [23], and also to be an indicator of the onset of multiple organ dysfunction
syndrome in multiple trauma [24]. Moreover, surgical and anesthesia trauma has also been reported to
elicit an increase in HMGB1, and the authors suggested a positive correlation between the release of
IL-6 and HMGB1 following traumatic insult [25]. On the other hand, certain anesthetics including
propofol [26], lidocaine [27,28], and remifentanil [29], were reported to inhibit the release of HMGB1.
Based on these previous findings, we asked whether different anesthetic techniques would be able to
lead to a difference in perioperative HMGB1 levels in elderly hip fracture patients undergoing surgical
treatment. However, it was unclear how the preceding trauma of the fracture and the subsequent
surgical/anesthesia would interact in terms of the release of HMGB1 and IL-6, and this is beyond the
scope of our study. Among routine laboratory blood tests that we assessed as secondary outcome,
low Hb, albumin, and TLC, and high creatinine, potassium, troponin T, and CRP have all been reported
be associated with poor outcome in hip fracture patients [3,30–32].
The pattern of alterations in HMGB1 and IL-6 observed in our present study was similar to
the observations of Giannoudis et al. [9], who reported an increase in HMGB1 later in the clinical
course compared to that of IL-6. Although we were unable to measure cytokine levels beyond POD2,
our results demonstrated that while IL-6 peaked on POD1 and started to decrease uniformly in all
groups on POD2, HMGB-1 continued to increase in the propofol group while decreasing slightly in the
desflurane and spinal groups on POD2. Unfortunately, we were unable to establish the predictive
value or correlations of these cytokines with different modes of anesthesia. This also applied to the
other laboratory blood tests that were evaluated in the present study. However, it is worth noting that
there was a steady decrease in Hb in all groups up to POD2 and a trend for increases in troponin T and
CRP after surgery.
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Most existing studies have compared outcomes between regional and general anesthesia. However,
the use of propofol-based TIVA has been reported to have positive outcomes compared to those
following volatile anesthetics, especially for cognitive function in the elderly [33–35]. Propofol has
antioxidant and anti-inflammatory properties [36], and can decrease the production of cytokines
including IL-6 [37]. We, thus, further divided the method of general anesthesia into propofol-based
TIVA and desflurane-based balanced anesthesia. However, we did not observe any difference in
the incidence of postoperative delirium among groups in the present study, potentially because
we only collected data on delirium and not postoperative cognitive dysfunction (POCD). Adding
neuropsychological testing before and after surgery would have provided deeper insight into the
ability of propofol anesthesia to improve cognitive function after hip fracture surgery in elderly
patients. Moreover, there were no differences in perioperative HMGB1, IL-6, and other routine
laboratory tests with propofol anesthesia compared to those of other anesthesia methods. One possible
explanation for this may be that the dose of propofol used in the patients was relatively small due
to short operation times and frailty of the elderly patients enrolled in this study. Moreover, the lack
of any difference in outcome between three anesthetic techniques may have been different in other
patient populations. The prospect of anesthesia being able to affect outcome after surgery is especially
exciting in the field of oncology. Both propofol and regional anesthesia have been suggested to have
immunomodulatory effects during the perioperative period in cancer patients [38,39], which ultimately
may lead to improvement in recurrence and long-term survival [40].
The main differences that were observed among the three groups were significantly lesser amounts
of intraoperative crystalloids administered and smaller number of patients that required vasopressors
in the spinal group compared to that in both the desflurane and propofol groups. These results are
similar to that of Biboulet et al. [41], where continuous spinal anesthesia was found to provide better
hemodynamic stability than general anesthesia with propofol TCI or sevoflurane in elderly patients
undergoing hip fracture surgery. Messina et al. also reported that spinal anesthesia provided a more
stable hemodynamic profile than that of general anesthesia with sevoflurane in elderly hip fracture
patients. [42] Although the precise degree and duration of perioperative hypotension that must be
avoided is unclear, there is a consensus that longer and more severe intraoperative hypotension
is associated with postoperative morbidity and mortality [43–45]. However, we did not analyze
the incidence of hypotensive events; rather, we focused on the number of patients in each group
who required multiple boluses of ephedrine or phenylephrine/norepinephrine administration for
hemodynamic control during surgery. Frail, elderly patients often require continuous infusions of
vasopressors rather than intermittent bolus administrations, which makes recording the exact number
of episodes of hypotension difficult.
The mortality rate observed in the present study was lower than previously reported mortality
rates at 3 months postoperatively. The overall survival rate up to 3 months after surgery for hip
fractures has been reported to be between 5.3% to 10.5% [6,46,47] regardless of method of anesthesia,
whereas the incidence observed in the present study was 1.7% to 3.3% in all groups. The reason for
this lower mortality rate at 3 months is unclear. As a single-center study, our institution receives a
high volume of elderly hip fracture patients and has a dedicated surgical and anesthesia team for this
patient population. All patients enrolled in the present study were managed by the same team of
anesthesiologists, and the level of experience and prompt response to intraoperative adverse events
may have contributed to the outcome.
The present study has several limitations, some of which are common to trials of similar design.
First, to truly randomize the method of anesthesia, we were unable to include patients taking certain
oral anticoagulants that are contraindications for regional anesthesia. Second, our results included
survival up to 90 days after surgery, with no difference observed in survival among the three groups.
However, as our sample size calculation was not conducted for the assessment of secondary outcomes,
such as postoperative morbidity and mortality, these results should be interpreted with caution. Third,
a longer period of postoperative follow-up would have been beneficial for assessing the longer-term
J. Clin. Med. 2020, 9, 1605 10 of 12
survival rate of patients enrolled in our study. Finally, the long-term functional impact, with regards
to mobilization and neurological function, including POCD and intraoperative BIS levels, were not
evaluated in our study. Regardless of the lower short-term mortality rate observed in our study,
a longer follow-up period would shed more light on the effects of different anesthesia methods on
patient function.
In conclusion, no differences in perioperative HMGB1 or IL-6 levels were observed between
geriatric hip fracture patients who received either balanced inhalation anesthesia with desflurane, TIVA
with propofol, or spinal anesthesia with local anesthetics. Clinical outcomes and other biological test
results were also comparable between groups. The sole statistically significant finding was a difference
in intraoperative fluid balance and the use of vasopressors between groups, but its clinical significance
is uncertain.
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